We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-6.08%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$39.8B
AUM Growth
-$2.49B
(-5.9%)
Cap. Flow
+$696M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
24.77%
Holding
1,335
New
62
Increased
793
Reduced
417
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$198M |
| 2 |
Synopsys
SNPS
|
+$159M |
| 3 |
Lam Research
LRCX
|
+$150M |
| 4 |
Intel
INTC
|
+$105M |
| 5 |
Western Union
WU
|
+$105M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$144M |
| 2 |
ServiceNow
NOW
|
+$108M |
| 3 |
Adobe
ADBE
|
+$108M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$104M |
| 5 |
B
Barrick Mining
B
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 36.37% |
| 2 | Technology | 23.79% |
| 3 | Energy | 8.84% |
| 4 | Healthcare | 6.99% |
| 5 | Financials | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DMB
801
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$193M
| $1.05M | ﹤0.01% |
67,263
-3,065
| -4% | -$47.2K |
|
|
HZNP
802
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.04M | ﹤0.01% |
9,463
+2,029
| +27% | +$211K |
|
803
Snap-on
SNA
$21.2B
| $1.03M | ﹤0.01% |
4,923
+424
| +9% | +$94K |
|
804
Labcorp
LH
$24.9B
| $1.03M | ﹤0.01% |
4,245
+871
| +26% | +$220K |
|
805
QuantumScape Corp
QS
$3.28B
| $1.02M | ﹤0.01% |
+41,618
| New | +$950K |
|
|
PMF
806
DELISTED
PIMCO Municipal Income Fund
PMF
| $1.01M | ﹤0.01% |
69,299
+582
| +0.8% | +$8.81K |
|
807
Enterprise Products Partners
EPD
$81.9B
| $1.01M | ﹤0.01% |
46,684
-2,098
| -4% | -$47.7K |
|
808
VanEck Energy Income ETF
EINC
$82.1M
| $995K | ﹤0.01% |
18,348
+5,651
| +45% | +$301K |
|
809
Repligen
RGEN
$8.3B
| $993K | ﹤0.01% |
3,437
-16
| -0.5% | -$4.11K |
|
|
HOLX
810
DELISTED
Hologic
HOLX
| $986K | ﹤0.01% |
13,361
+3,875
| +41% | +$291K |
|
811
Booz Allen Hamilton
BAH
$8.56B
| $982K | ﹤0.01% |
12,377
+1,064
| +9% | +$88.9K |
|
812
Encompass Health
EHC
$11.2B
| $965K | ﹤0.01% |
+16,160
| New | +$1.02M |
|
|
NBH
813
Neuberger Municipal Fund Inc
NBH
$300M
| $965K | ﹤0.01% |
60,103
+8,411
| +16% | +$137K |
|
814
Universal Health Services
UHS
$10.2B
| $958K | ﹤0.01% |
6,924
+1,780
| +35% | +$269K |
|
815
Nuveen Select Tax-Free Income Portfolio
NXP
$892M
| $953K | ﹤0.01% |
54,850
+10,904
| +25% | +$191K |
|
816
CBRE Group
CBRE
$43B
| $950K | ﹤0.01% |
9,755
+2,814
| +41% | +$261K |
|
817
Cenovus Energy
CVE
$54.5B
| $948K | ﹤0.01% |
94,229
-11,415
| -11% | -$97.5K |
|
818
iShares Global Infrastructure ETF
IGF
$10.9B
| $948K | ﹤0.01% |
20,645
+8,910
| +76% | +$411K |
|
819
Revvity
RVTY
$12.9B
| $943K | ﹤0.01% |
5,443
+229
| +4% | +$40.4K |
|
820
Badger Meter
BMI
$3.97B
| $940K | ﹤0.01% |
9,298
-304
| -3% | -$31.1K |
|
821
Bio-Rad Laboratories Class A
BIO
$8.96B
| $938K | ﹤0.01% |
1,257
+88
| +8% | +$65.9K |
|
822
Global X US Infrastructure Development ETF
PAVE
$14.9B
| $928K | ﹤0.01% |
36,511
+11,120
| +44% | +$293K |
|
823
Sun Life Financial
SLF
$45.7B
| $928K | ﹤0.01% |
18,057
+3,184
| +21% | +$164K |
|
824
Tower Semiconductor
TSEM
$26.5B
| $926K | ﹤0.01% |
30,985
-2,278
| -7% | -$65.6K |
|
825
HF Sinclair
DINO
$15.8B
| $924K | ﹤0.01% |
27,899
-2,004
| -7% | -$60.9K |
|
Similar funds
VanEck Associates's Q3 2021 Portfolio in Review
As of Q3 2021, VanEck Associates held 1,335 positions worth $39.8B, down 5.9% from $42.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VanEck Associates's Q3 2021 filing shows 62 new, 793 increased, 417 reduced and 46 closed positions. Its largest new stake was Synopsys: 523,038 shares worth $157M. The largest sale was Newmont, an estimated $144M.
By sector, the portfolio is most concentrated in Materials at 36% of assets, down from 40% a quarter earlier, followed by Technology and Energy.
- VanEck Associates's largest Q3 2021 buy was Synopsys: 523,038 shares worth $157M.
- VanEck Associates added most to TSMC in Q3 2021, an estimated $198M increase.
- VanEck Associates's biggest Q3 2021 reduction was Newmont, cutting an estimated $144M.
- VanEck Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $104M.
- VanEck Associates's ten largest holdings make up 25% of its $39.8B portfolio in Q3 2021.
- VanEck Associates opened 62 new positions and closed 46 in Q3 2021.
- VanEck Associates's portfolio value fell 5.9% quarter-over-quarter to $39.8B.
Based on VanEck Associates's 13F filing for Q3 2021, filed 3 Nov 2021.